Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Burhan Hazar, Semra Paydas, Suzan Zorludemir, Berksoy Sahin & Ilhan Tuncer. (2003) Prognostic Significance of Microvessel Density and Vascular Endothelial Growth Factor (VEGF) Expression in non-Hodgkin's Lymphoma. Leukemia & Lymphoma 44:12, pages 2089-2093.
Read now
Read now
V. Eleutherakis-Papaiakovou, M. Karali, I. Kokkonouzis, I. Tiliakos & M.A. Dimopoulos. (2003) Bone Marrow Angiogenesis and Progression in Multiple Myeloma: Clinical Significance and Therapeutic Approach. Leukemia & Lymphoma 44:6, pages 937-948.
Read now
Read now
Articles from other publishers (11)
Byung-Gyu Kim, Sung Hee Choi, John J. Letterio, Jie-Young Song & Alex Y. Huang. (2022) Overexpression of VEGF in the MOPC 315 Plasmacytoma Induces Tumor Immunity in Mice. International Journal of Molecular Sciences 23:9, pages 5235.
Crossref
Crossref
Elena Evgen'evna Nikulina, M.V. Firsova, N.V. Risinskaya, Ya.A. Kozhevnikova, M.V. Solov'ev, T.V. Abramova, T.N. Obukhova, A.M. Kovrigina, A.B. Sudarikov & L.P. Mendeleeva. (2022) Evaluation of Heterozygosity Loss in STR-Loci of Tumor DNA in Multiple Myeloma Patients with Plasmacytoma Based on the Molecular Analysis of Complex Archival Tumor Samples. Clinical oncohematology 15:2, pages 156-166.
Crossref
Crossref
Eirini Katodritou, Evangelos Terpos, Argiris S. Symeonidis, Anastasia Pouli, Charikleia Kelaidi, Marie-Christine Kyrtsonis, Maria Kotsopoulou, Sosana Delimpasi, Anna Christoforidou, Nikolaos Giannakoulas, Nora-Athina Viniou, Ekaterini Stefanoudaki, Christina Hadjiaggelidou, Dimitrios Christoulas, Evgenia Verrou, Vassiliki Gastari, Sofia Papadaki, Genovefa Polychronidou, Athina Papadopoulou, Evlambia Giannopoulou, Efstathios Kastritis, Alexandra Kouraklis, Pavlina Konstantinidou, Achilles Anagnostopoulos, Konstantinos Zervas & Meletios A. Dimopoulos. (2014) Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients. American Journal of Hematology 89:8, pages 803-808.
Crossref
Crossref
Antoine Néel, Muriel Hello, Sebastien Barbarot, Frédérique Jossic, Agathe Masseau, Olivier Espitia, Jean-Marie Mussini, Philippe Moreau, Lucile Musset & Mohamed Hamidou. (2012) Skin Patch, Polyneuropathy, and Paraproteinemia. The American Journal of Medicine 125:12, pages e1-e2.
Crossref
Crossref
C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, K.C.C. Aguiar, M.R.R. Silva & J.O. Bordin. (2005) Plasmablastic multiple myeloma is associated with increased vascular endothelial growth factor immunoexpression. Brazilian Journal of Medical and Biological Research 38:11, pages 1609-1613.
Crossref
Crossref
Shenxian QianGeorge SomloBingsen ZhouLijun ZhuShu MiXueli MoEric M. CheungWeihua QiuRen-Jang LinJohn RossiMelissa HoltzPeiguo ChuYun Yen. (2005) Ribozyme Cleavage Leads to Decreased Expression of Fibroblast Growth Factor Receptor 3 in Human Multiple Myeloma Cells, Which Is Associated with Apoptosis and Downregulation of Vascular Endothelial Growth Factor. Oligonucleotides 15:1, pages 1-11.
Crossref
Crossref
Christian Ribas, Gisele W. B. Colleoni, Maria Regina Regis Silva, Maria José Carregoza & José Orlando Bordin. (2004) Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma. European Journal of Haematology 73:5, pages 311-317.
Crossref
Crossref
Xiao Yan Yang, Meera Hameed, Eun-Sook Cho & Kasturi Das. (2004) Pathologic Quiz Case: Sacral/Pelvic Mass With Lower Back Pain in a 36-Year-Old Man. Archives of Pathology & Laboratory Medicine 128:2, pages 237-238.
Crossref
Crossref
Hirofumi NAGANUMA, Satoshi SAKATSUME, Masao SUGITA, Eiji SATOH, Takayuki ASAHARA & Hideaki NUKUI. (2004) Solitary Plasmacytoma of the Skull: Immunohistochemical Study of Angiogenic Factors and Syndecan-1-Two Case Reports-. Neurologia medico-chirurgica 44:4, pages 195-200.
Crossref
Crossref
Maurizio Zangari, Elias Anaissie, Alison Stopeck, Alyssa Morimoto, Nguyen Tan, Jeffrey Lancet, Maureen Cooper, Alison Hannah, Guillermo Garcia-Manero, Stephan Faderl, Hagop Kantarjian, Julie Cherrington, Maher Albitar & Francis J. Giles. (2004) Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma. Clinical Cancer Research 10:1, pages 88-95.
Crossref
Crossref
Shaji KumarRafael FonsecaAngela DispenzieriMartha Q. LacyJohn A. LustLinda WellikThomas E. WitzigMorie A. GertzRobert A. KylePhilip R. GreippS. Vincent Rajkumar. (2003) Prognostic value of angiogenesis in solitary bone plasmacytoma. Blood 101:5, pages 1715-1717.
Crossref
Crossref